BeOne Medicines (ONC) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for BeOne Medicines (ONC) over the last 9 years, with Q3 2025 value amounting to $0.08.
- BeOne Medicines' EPS (Weighted Average and Diluted) rose 18888.89% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.03, marking a year-over-year increase of 10468.75%. This contributed to the annual value of -$0.47 for FY2024, which is 2769.23% up from last year.
- As of Q3 2025, BeOne Medicines' EPS (Weighted Average and Diluted) stood at $0.08, which was up 18888.89% from $0.06 recorded in Q2 2025.
- Over the past 5 years, BeOne Medicines' EPS (Weighted Average and Diluted) peaked at $0.15 during Q3 2023, and registered a low of -$0.49 during Q4 2021.
- For the 5-year period, BeOne Medicines' EPS (Weighted Average and Diluted) averaged around -$0.19, with its median value being -$0.26 (2023).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 76000.0% in 2022, then surged by 18888.89% in 2025.
- BeOne Medicines' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.49 in 2021, then soared by 32.65% to -$0.33 in 2022, then increased by 18.18% to -$0.27 in 2023, then skyrocketed by 59.26% to -$0.11 in 2024, then soared by 172.73% to $0.08 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.08 for Q3 2025, versus $0.06 for Q2 2025 and $0.0 for Q1 2025.